Zentek (NASDAQ:ZTEK) Stock Price Down 0.1% - Should You Sell?

Key Points

• Zentek Ltd. (NASDAQ:ZTEK) experienced a slight decline in share price, down 0.1% to $0.88, with a trading volume significantly lower than the average.
• Financial metrics indicate a negative return on equity of 55.41% and a negative net margin of 981.17%, while the company reported earnings of ($0.01) per share for the last quarter.
• Zentek is involved in the research and development of graphene and related nanomaterials, creating products such as antimicrobial coatings, surgical masks, and rapid diagnostic tests.

Shares of Zentek Ltd. (NASDAQ:ZTEK - Get Free Report) dropped 0.1% during trading on Wednesday . The company traded as low as $0.86 and last traded at $0.88. Approximately 56,106 shares were traded during trading, a decline of 93% from the average daily volume of 824,056 shares. The stock had previously closed at $0.89.

Zentek Stock Down 6.2%

The firm has a market cap of $99.21 million, a P/E ratio of -18.95 and a beta of 0.59. The stock's 50 day simple moving average is $0.86 and its 200 day simple moving average is $1.13. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.30 and a current ratio of 1.62.

Zentek (NASDAQ:ZTEK - Get Free Report) last announced its quarterly earnings results on Thursday, August 14th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.04 million for the quarter. Zentek had a negative net margin of 981.17% and a negative return on equity of 55.41%.

Zentek Company Profile

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.